<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>12 Megaloblastic anaemia II: Folate deficiency and other macrocytic anaemias</title>
    <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700&display=swap" rel="stylesheet">
    <link rel="stylesheet" href="../styles/main.css">
    <!-- Include MathJax -->
    <script>
    MathJax = {
        tex: {
            inlineMath: [['$', '$'], ['\\(', '\\)']],
            displayMath: [['$$', '$$'], ['\\[', '\\]']],
            processEscapes: true,
            processEnvironments: true,
            tags: 'ams' // Use AMS numbering of equations
        },
        svg: { fontCache: 'global' },
        options: {
            skipHtmlTags: ['script', 'noscript', 'style', 'textarea', 'pre']
        }
    };
    </script>
    <script src="https://polyfill.io/v3/polyfill.min.js?features=es6"></script>
    <script id="MathJax-script" async src="https://cdn.jsdelivr.net/npm/mathjax@3/es5/tex-mml-chtml.js"></script>
</head>
<body>
    <div class="container">
        <article class="document-section" role="main">
            <!-- Top Navigation -->
            <nav class="document-nav" role="navigation" aria-label="Document Sections">
                <div class="nav-links">
                    <a href="../index.html" class="nav-button">
                        <span class="nav-icon"></span>
                        <span class="nav-text">Table of Contents</span>
                    </a>
                    <a href="haematology-11-megaloblastic-anaemia-I-vitamin-B12-deficiency.html" class="nav-button">
                        <span class="nav-icon">←</span>
                        <span class="nav-text">Previous Section</span>
                    </a>
                    <div class="document-progress">
                         <div class="progress-bar" aria-hidden="true">
                            <div class="progress-fill" style="width: 30%;"></div>
                        </div>
                       <span class="progress-text">Lecture 12 of 40</span>
                    </div>
                    <a href="haematology-13-haemolytic-anaemias-I-general.html" class="nav-button">
                        <span class="nav-text">Next Section</span>
                        <span class="nav-icon">→</span>
                    </a>
                </div>
            </nav>

            <header class="section-header">
                <h1 class="section-title">12 Megaloblastic anaemia II: Folate deficiency and other macrocytic anaemias</h1>
                <div class="title-underline"></div>
            </header>

            <main class="section-content">
                
                <section id="physiology" class="content-section" aria-labelledby="section-heading-1">
                    <h2 id="section-heading-1" class="section-heading">
                        <span class="heading-text">Physiology</span>
                    </h2>
                    <div class="content-card">
                        <p>Folates consist of a large number of compounds derived from the parent compound pteroylglutamic (folic) acid by reduction, addition of single carbon groups, e.g. methyl or formyl, and, in cells, addition of extra glutamate moieties usually four, five or six (see Fig.11.1).</p>
                        <ul>
                            <li>Occur in most foods, especially liver and green vegetables. Normal daily diet contains $200-250 \mu \mathrm{g}$, of which about $50\%$ is absorbed.</li>
                            <li>Daily adult requirements are about $100 \mu \mathrm{g}$; body stores are sufficient for 4 months.</li>
                            <li>Absorbed through the upper small intestine with conversion of all natural forms to 5-methyl tetrahydrofolate (methyl THF).</li>
                        </ul>
                    </div>
                </section>

                <section id="clinical-features" class="content-section" aria-labelledby="section-heading-2">
                    <h2 id="section-heading-2" class="section-heading">
                        <span class="heading-text">Clinical features</span>
                    </h2>
                    <div class="content-card">
                        <p>The clinical features of folate deficiency are the same as B<sub>12</sub> deficiency, but folate deficiency does not cause a similar neuropathy. Folic acid therapy in early pregnancy reduces neural tube defects (anencephaly, spina bifida, encephalocoele) in the fetus, probably by reducing homocysteine accumulation. Conversion of homocysteine to methionine requires the folate coenzyme methyl THF (see Fig. 11.1).</p>
                    </div>
                </section>

                <section id="causes-of-folate-deficiency" class="content-section" aria-labelledby="section-heading-3">
                    <h2 id="section-heading-3" class="section-heading">
                        <span class="heading-text">Causes of folate deficiency (Table 12.1)</span>
                    </h2>
                    <div class="content-card">
                        <ul>
                            <li>The most common cause is poor dietary intake, either alone or in association with increased folate utilization (e.g. pregnancy or haemolytic anaemia).</li>
                            <li>Malabsorption occurs in gluten-induced enteropathy or tropical sprue.</li>
                            <li>Increased utilization. Increased cell turnover and DNA synthesis causes breakdown of folates; the most common causes include pregnancy, haemolytic anaemia, severe chronic inflammatory and malignant diseases, and anticonvulsant drugs.</li>
                            <li>Folate is loosely bound to protein in plasma and is easily removed by dialysis.</li>
                        </ul>
                        <div class="table-container">
                            <table class="content-table">
                                <caption>Table 12.1 Causes of folate deficiency.</caption>
                                <tbody>
                                    <tr><td><strong>Nutritional</strong></td></tr>
                                    <tr><td>Especially old age, institutions, poverty, famine</td></tr>
                                    <tr><td><strong>Malabsorption</strong></td></tr>
                                    <tr><td>Gluten-induced enteropathy, dermatitis herpetiformis, tropicalsprue</td></tr>
                                    <tr><td><strong>Excess utilization</strong></td></tr>
                                    <tr><td><strong>Physiological</strong><br>Pregnancy and lactation, prematurity</td></tr>
                                    <tr><td><strong>Pathological</strong><br>Haematological diseases: haemolytic anaemias, myelofibrosis<br>Malignant diseases: carcinoma, lymphoma, myeloma<br>Inflammatory diseases: Crohn's disease, rheumatoid arthritis,extensive psoriasis, exfoliative dermatitis, malaria</td></tr>
                                    <tr><td><strong>Excess urinary folate loss</strong></td></tr>
                                    <tr><td>Congestive heart failure, chronic dialysis</td></tr>
                                    <tr><td><strong>Drugs</strong></td></tr>
                                    <tr><td>Anti-convulsants, sulphasalazine</td></tr>
                                    <tr><td><strong>Mixed</strong></td></tr>
                                    <tr><td>Liver disease, alcoholism (spirit drinkers)</td></tr>
                                </tbody>
                            </table>
                        </div>
                    </div>
                </section>

                <section id="tests-for-causes" class="content-section" aria-labelledby="section-heading-4">
                    <h2 id="section-heading-4" class="section-heading">
                        <span class="heading-text">Tests for causes of deficiency</span>
                    </h2>
                    <div class="content-card">
                        <p>These include history (diet, previous surgery, drug therapy, alcohol, other associated diseases), antigliadin and endomysial antibodies, and tests for malabsorption (e.g. duodenal biopsy). The serum folate is low, red cell folate is low and serum B<sub>12</sub> is normal or slightly reduced.</p>
                    </div>
                </section>

                <section id="treatment" class="content-section" aria-labelledby="section-heading-5">
                    <h2 id="section-heading-5" class="section-heading">
                        <span class="heading-text">Treatment</span>
                    </h2>
                    <div class="content-card">
                        <p>Treatment is 5 mg folic acid daily for 4 months, then decide whether to continue folic acid, e.g. 5 mg folic acid once weekly indefinitely. Folate therapy corrects the anaemia but not the neuropathy of B<sub>12</sub> deficiency. Indeed, administration of folate to a severely B<sub>12</sub>-deficient individual may precipitate or worsen B<sub>12</sub> neuropathy. Pregnant women are given about $400 \mu \mathrm{g}$ daily to reduce the incidence of megaloblastic anaemia and of neural tube defects in the fetus.</p>
                    </div>
                </section>

                <section id="other-causes-ma" class="content-section" aria-labelledby="section-heading-6">
                    <h2 id="section-heading-6" class="section-heading">
                        <span class="heading-text">Other causes of megaloblastic anaemia</span>
                    </h2>
                    <div class="content-card">
                        <p>Defects of B<sub>12</sub> or folate metabolism include congenital transcobalamin (TC) II deficiency which leads to B<sub>12</sub> malabsorption and to failure of B<sub>12</sub> to enter cells resulting in megaloblastic anaemia (MA) in early infancy. N<sub>2</sub>O anaesthesia reversibly inactivates body B<sub>12</sub> and prolonged or repeated exposure may cause megaloblastic anaemia or B<sub>12</sub> neuropathy. Antifolate drugs include the inhibitors of dihydrofolate reductase (methotrexate, pyrimethamine and trimethoprim) which have progressively less activity against the human compared to the bacterial enzyme. Folinic acid (5-formyl-THF) is used to overcome methotrexate toxicity. Megaloblastic anaemia also occurs with cytotoxic drug therapy (e.g. 6-mercaptopurine, cytosine arabinoside or hydroxyurea (hydroxycarbamide)) or, rarely, inborn errors, e.g. orotic aciduria.</p>
                    </div>
                </section>

                <section id="causes-of-macrocytosis" class="content-section" aria-labelledby="section-heading-7">
                    <h2 id="section-heading-7" class="section-heading">
                        <span class="heading-text">Causes of macrocytosis</span>
                    </h2>
                    <div class="content-card">
                        <p>Alcohol is the most frequent cause (Table 12.2). MCV is not usually as high as in severe MA in these conditions. White cell and platelet counts are normal unless the underlying marrow disease affects these, the red cells are circular rather than oval, hypersegmented neutrophils are absent and the marrow is normoblastic.</p>
                        <div class="table-container">
                             <table class="content-table">
                                 <caption>Table 12.2 Causes of raised MCV other than megaloblastic anaemia.</caption>
                                 <tbody>
                                     <tr><td>1 Alcohol</td></tr>
                                     <tr><td>2 Liver disease</td></tr>
                                     <tr><td>3 Myxoedema</td></tr>
                                     <tr><td>4 Reticulocytosis</td></tr>
                                     <tr><td>5 Cytoxic drugs</td></tr>
                                     <tr><td>6 Aplastic anaemia</td></tr>
                                     <tr><td>7 Pregnancy</td></tr>
                                     <tr><td>8 Myelodysplastic syndromes</td></tr>
                                     <tr><td>9 Myeloma</td></tr>
                                     <tr><td>10 Neonatal</td></tr>
                                 </tbody>
                             </table>
                        </div>
                    </div>
                </section>

            </main>

            <!-- Bottom Navigation -->
             <nav class="document-nav" role="navigation" aria-label="Document Sections">
                <div class="nav-links">
                    <a href="../index.html" class="nav-button">
                        <span class="nav-icon"></span>
                        <span class="nav-text">Table of Contents</span>
                    </a>
                    <a href="haematology-11-megaloblastic-anaemia-I-vitamin-B12-deficiency.html" class="nav-button">
                        <span class="nav-icon">←</span>
                        <span class="nav-text">Previous Section</span>
                    </a>
                    <div class="document-progress">
                         <div class="progress-bar" aria-hidden="true">
                            <div class="progress-fill" style="width: 30%;"></div>
                        </div>
                       <span class="progress-text">Lecture 12 of 40</span>
                    </div>
                    <a href="haematology-13-haemolytic-anaemias-I-general.html" class="nav-button">
                        <span class="nav-text">Next Section</span>
                        <span class="nav-icon">→</span>
                    </a>
                </div>
            </nav>

        </article>
    </div>
    <script src="../js/navigation.js"></script>
</body>
</html>